Rachel C. Sisodia, M.D.

Senior Medical Director for Specialty Care and Patient-Reported Outcomes
Quality and Patient Experience

Rachel C. SisodiaRachel C. Sisodia, M.D. is a Gynecologic Oncologist on staff at the Massachusetts General Hospital and an Associate Professor of Obstetrics, Gynecology and Reproductive Endocrinology at Harvard Medical School. Within her clinical practice she performs surgeries, administers chemotherapy and provides palliative care to women suffering from gynecologic malignancy. In addition to her academic and clinical work, Dr. Sisodia is also a Medical Director in Population Health Management for the Massachusetts General Physicians Organization (MGPO) and Senior Medical Director for Specialty Care Patient Reported Outcomes (PROMs) at Mass General Brigham.

Dr. Sisodia is recognized both nationally and internationally as an expert on PROMs, with a particular focus on the implementation science of building large, pragmatic and usable clinical PROM programs. This expertise is brought to life within her role as the Senior Medical Director for Specialty Care and Patient Reported Outcomes for Mass General Brigham. Within that role she is responsible for the implementation, management and strategy of PROMs within the Mass General Brigham enterprise, which cares for millions of patients a year. During her tenure, the Mass General Brigham digital PROMS program has grown to be the largest in the world and includes 250 clinics, over 100 different geographic locations, almost 100 specialties and disease sites and the collection of more than 12,000,000 patient reported outcome questionnaires. As part of the system’s United Against Racism effort, she has spearheaded the world’s largest Patient Reported Outcome Measure translation project, overseeing the translations, quality assurance, and embedding of more than 6,000 uniquely translated PROMs into the EPIC health record as well as the backwards translation into English for the PROMS central data mart.

Dr. Sisodia serves on diverse technical advisory panels and advisory groups on PROMs throughout the nation, including a seat on the prestigious U.S National PROMS Steering Committee; other committee members include the senior most leadership of National Quality Forum (NQF) and Centers for Medicaid and Medicare Services (CMS). She is also a technical expert panel member for National Quality Forum (NQF) as well as EPIC Health Systems. In addition, she is the Scientific Co-Chair for the 2022 PROMIS International Conference to be held in Prague, Czech Republic. In addition to her broader work in PROMs, she remains deeply committed to the clinical care of women with gynecologic malignancy and serves as a Co-Chair of the Society of Gynecologic Oncology’s (SGO) Policy, Quality and Outcomes Committee, where she has been the guiding voice for the current standard of care for PROMs in the care of women with gynecologic malignancy.

Finally, in addition to her deep passion for the use of PROMs in the care of all patients, Dr. Sisodia remains firmly committed to improving both the quality and safety of surgical and specialty care through rigor, teamwork and adherence to implementation science. As the Senior Medical Director for Specialty Care and Patient Reported Outcomes, Dr. Sisodia also oversees all quality and safety for specialty care (19 Departments) across Mass General Brigham.